Through treatment with TMZ (the current gold standard of glioblastoma chemotherapy) and NF-κB BAY 11-7082, researchers have shown increased apoptosis in patient-derived glioblastoma cell lines [83]. The gene discussed is NFKB1; the disease is glioblastoma.